Avadel Pharmaceuticals (AVDL)
(Real Time Quote from BATS)
$15.59 USD
+0.08 (0.52%)
Updated Aug 12, 2024 11:20 AM ET
3-Hold of 5 3
F Value C Growth A Momentum C VGM
Industry / Sector Report
Industry : Medical - Drugs
Zacks Industry Rank
Top 39% (98 out of 250)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.10 | 1.52 | 9.99 |
Current Quarter Estimate | -0.07 | -2.04 | 61.00 |
Year Ago Quarter Estimate | -0.41 | -0.59 | 54.84 |
Next Quarter Estimate | 0.00 | -2.00 | 63.00 |
Next Year Estimate | 0.56 | 6.92 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 72.50 | 16.20 | 15.67 |
Next Year | 201.82 | 16.60 | 11.34 |
Last 5 Years | NA | 7.00 | 8.10 |
Next 5 Years | NA | 23.00 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | -5.88 |
Price/Book (MRQ) | 21.21 | 1.58 |
Price/Cash Flow (MRFY) | NA | 8.47 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -111.64% | 6.02% |
Return on Equity (TTM) | -122.64% | 7.75% |
Debt to Equity (MRQ) | 0.00 | 2.23 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.